Next Article in Journal
The First Results of Extended Newborn Screening in Slovakia—Differences between the Majority and the Roma Ethnic Group
Previous Article in Journal
Regional Variation in the Incidence of Congenital Hypothyroidism in Macedonia
Previous Article in Special Issue
Indifferent or Uninformed? Reflections of Health Professionals on Parental Education and Consent for Expanded Newborn Screening in Israel, 2008–2016
Article Menu

Export Article

Open AccessConference Report
Int. J. Neonatal Screen. 2017, 3(3), 23; https://doi.org/10.3390/ijns3030023

Gunnar Jungner and the Principles and Practice of Screening for Disease

1
Son of Gunnar Jungner, Master of Business Administration, University of Stockholm, SE-106 91 Stockholm, Sweden
2
Unit of Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, 17177 Stockholm, Sweden
3
Centre for Inherited Metabolic Diseases, Karolinska University Hospital, 17176 Stockholm, Sweden
4
Department of Molecular Medicine and Surgery, Karolinska Institutet, 17177 Stockholm, Sweden
5
Department of Medical Biochemistry and Biophysics, Karolinska Institutet, 17177 Stockholm, Sweden
*
Author to whom correspondence should be addressed.
Received: 27 June 2017 / Revised: 15 August 2017 / Accepted: 16 August 2017 / Published: 21 August 2017
(This article belongs to the Special Issue Newborn Screening-Past, Present and Future)
View Full-Text   |   Download PDF [6714 KB, uploaded 22 August 2017]   |  

Abstract

We present a biography of Gunnar Jungner, one of the authors of the Principles and Practice of Screening for Disease by JMG Wilson and G Jungner, published by the WHO in 1968. This publication contains ten criteria, which are still consulted, when a new disorder is evaluated for inclusion in a screening program. Gunnar Jungner was a Swedish MD, PhD, specialized in Clinical Chemistry, born in Sweden in 1914. In 1961 he built an automated instrument for the analysis of different components in plasma, with the aim to detect diseases in presumably healthy individuals, to enable start of treatment at an early disease stage. This first automated instrument for Clinical Chemistry in Sweden was used in a screening project, where 90 000 seemingly healthy individuals were included. The study was discussed extensively and he was invited to present the results at different international meetings, where he also met JMG Wilson. Gunnar Jungner developed the instrument further together with his brother Ingmar and the Swedish gas company AGA. The brothers also established an out-patient ward in Stockholm, where people could come for health screening. View Full-Text
Keywords: screening; pre-symptomatic; Jungner; biography screening; pre-symptomatic; Jungner; biography
Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).
SciFeed

Share & Cite This Article

MDPI and ACS Style

Jungner, L.; Jungner, I.; Engvall, M.; Döbeln, U. Gunnar Jungner and the Principles and Practice of Screening for Disease. Int. J. Neonatal Screen. 2017, 3, 23.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Int. J. Neonatal Screen. EISSN 2409-515X Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top